AI2M: New biomedical AI center at the Max Delbrück Center
The "Center for AI-Accelerated Molecular Innovations in Medicine" (AI2M) is being established at the Max Delbrück Center in Berlin. It is being funded with 30.8 million euros from the Helmholtz Association. The aim is to develop AI-based strategies for the precise...
New analysis method reveals harmful substances in cosmetics
Researchers at Justus Liebig University Giessen (JLU ) have used an innovative analytical method to detect harmful substances in lifestyle products that previous tests and regulatory requirements do not cover. They examined 140 care products, cosmetics from 20 product...
4R: Max Planck Institutes focus on ethical animal experiments and alternative methods
Animal experiments remain indispensable in basic biomedical research, but must be ethically justified and supplemented by alternative methods, as researchers at the Max Planck Institutes emphasize. At the Max Planck Institute for Biological Cybernetics in Tübingen,...
Würzburg University Hospital launches world’s first ROR1 CAR T-cell study in adrenal carcinoma
The University Hospital of Würzburg (UKW) has reached a milestone in cancer research: as part of the clinical phase I study LION-1, the first patient was treated with ROR1-specific CAR-T cells, a new type of immune cell therapy against cancer cells that carry the ROR1...
Kiel researchers decipher microbial infection protection in nematodes
Researchers from the Collaborative Research Center (CRC) 1182 at Kiel University (CAU ) have used the nematode Caenorhabditis elegans to demonstrate how an intestinal bacterium of the genus Pseudomonas uses a novel metabolic pathway to produce sphingolipids, which...
Sensation: Sustainable process revolutionizes synthesis of bioactive molecules
Chemists at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU ) have developed a groundbreaking process that enables the production of bioactive cyclic amine compounds without external enzyme or metal catalysts, as reported in the renowned scientific journal...
INQUIRED: “It’s a difficult situation, especially for relatives”
When a family member has to be treated for severe brain damage, this is also a difficult situation for relatives, who are usually unprepared. For relatives of patients in the neurointensive care unit and in early rehabilitation, it can be very helpful to have a family...
44th DGS Annual Congress starts in Stuttgart
The 44th Annual Congress of the German Society of Senology begins today at the International Congress Center Stuttgart. Experts, patient associations and representatives from politics and industry will be meeting until June 28 to discuss advances in the prevention,...
NCT Dresden starts Phase 2 trial with mRNA vaccine against pancreatic cancer
The National Center for Tumor Diseases (NCT/UCC) Dresden is offering patients with pancreatic cancer an innovative treatment with the mRNA-based cancer vaccine Autogene Cevumeran as part of the international phase 2 trial IMCODE003 (NCT05968326). The vaccine developed...
Consultation version of the S3 guideline on prostate cancer is online
The update of the S3 guideline on prostate cancer under the auspices of the German Society of Urology (DGU ) was eagerly awaited by experts: Due to the changed study situation, the scientific society had already held out the prospect of significant modifications to...
